$Krystal Biotech (KRYS.US)$ 10% Shareholder Krishnan Krish S sold 50,000 shares of common stock on Sep 12, 2024 at an average price of $197.7655 for a total value of $9.89 million.
This transaction involves other related parties: Krishnan Suma.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.